A Unifying Theory for Idiopathic Nephrotic Syndrome Pathogenesis?

Cutting Edge: Neutrophil Complement Receptor Signaling Is Required for BAFF-Dependent Humoral Responses in Mice

(2023) Arun Cumpelik et al.   JOURNAL OF IMMUNOLOGY

B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover

(2022) Manuela Colucci et al.   Frontiers in Immunology

B-cell activating factor (BAFF) and its receptors’ expression in pediatric nephrotic syndrome is associated with worse prognosis

(2022) Jessica Forero-Delgadillo et al.   PLoS One

Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial

(2021) Pietro Ravani et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults

(2020) Julie Oniszczuk et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Follicular B2 Cell Activation and Class Switch Recombination Depend on Autocrine C3ar1/C5ar1 Signaling in B2 Cells

(2019) Jacob Paiano et al.   JOURNAL OF IMMUNOLOGY

Complement Activation in Patients with Focal Segmental Glomerulosclerosis

(2015) Joshua M. Thurman et al.   PLoS One

Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome

(2014) P. Ruggenenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY